To hear about similar clinical trials, please enter your email below
Trial Title:
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT ID:
NCT06136962
Condition:
Nasopharyngeal Carcinoma
Conditions: Official terms:
Carcinoma
Nasopharyngeal Carcinoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer. The last three decades
of research in head and neck radiation oncology have largely focused on improvements in
survival, which have mostly come at the cost of long term toxicity for surviving
patients.This is an observational study that is being done to evaluate the long-term
efficacy, learn about the toxicity and quality of life that survivors of nasopharyngeal
carcinoma may have following treated with reduced volume intensity modulated radiation
therapy.
Criteria for eligibility:
Study pop:
Histologically diagnosed non-metastatic Nasopharyngeal carcinoma (NPC) patients who were
treated with Reduced Volume Intensity Modulated Radiation Therapy.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Received treatment with Reduced Volume Intensity Modulated Radiation Therapy
- Age 18 or above, upper limit 65
- Ability to comply with the protocol
Exclusion Criteria:
- History of recurrent nasopharyngeal disease
- A history of any physical, psychological or social condition which would impair with
the ability of the patient to cooperate in this study
- Unable to provide consent
Gender:
All
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of radiation oncology, Fujian cancer hospital
Address:
City:
Fuzhou
Zip:
350014
Country:
China
Contact:
Last name:
Shaojun Lin, doctor
Phone:
0591-62752225
Email:
linshaojun@yeah.com
Start date:
December 1, 2023
Completion date:
December 1, 2024
Lead sponsor:
Agency:
Fujian Cancer Hospital
Agency class:
Other
Source:
Fujian Cancer Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06136962
